These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35243514)

  • 1. Cerebrospinal fluid concentrations of cefiderocol during the treatment of extensively drug-resistant Pseudomonas aeruginosa ventriculitis.
    Luque-Paz D; Bennis Y; Jaubert P; Dubée V; Wolff M; Mortaza S
    J Antimicrob Chemother; 2022 May; 77(6):1787-1789. PubMed ID: 35243514
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrathecal colistin for treatment of multidrug resistant (MDR) Pseudomonas aeruginosa after neurosurgical ventriculitis.
    Baiocchi M; Catena V; Zago S; Badolati L; Baccarin M
    Infez Med; 2010 Sep; 18(3):182-6. PubMed ID: 20956875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa.
    Edgeworth JD; Merante D; Patel S; Young C; Jones P; Vithlani S; Wyncoll D; Roberts P; Jones A; Den Nagata T; Ariyasu M; Livermore DM; Beale R
    Clin Infect Dis; 2019 May; 68(11):1932-1934. PubMed ID: 30418554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of ventriculitis caused by
    Gofman N; To K; Whitman M; Garcia-Morales E
    Am J Health Syst Pharm; 2018 Jul; 75(13):953-957. PubMed ID: 29941534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion of ceftolozane-tazobactam resulted in high cerebrospinal fluid concentrations of ceftolozane in a patient with multidrug-resistant Pseudomonas aeruginosa meningitis.
    Winans SA; Guerrero-Wooley RL; Park SH; Hino G; Forland SC
    Infection; 2021 Apr; 49(2):355-359. PubMed ID: 32862306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of Cefiderocol Non-Susceptibility in Pseudomonas aeruginosa in a Patient Without Previous Exposure to the Antibiotic.
    Streling AP; Al Obaidi MM; Lainhart WD; Zangeneh T; Khan A; Dinh AQ; Hanson B; Arias CA; Miller WR
    Clin Infect Dis; 2021 Dec; 73(11):e4472-e4474. PubMed ID: 33411899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefiderocol treatment of Pseudomonas aeruginosa and extensively drug-resistant Acinetobacter baumannii retained spinal hardware infection causing reversible acute interstitial nephritis: Recto: Cefiderocol causing acute interstitial nephritis.
    Cipko K; Kizny Gordon A; Adhikari S; Konecny P
    Int J Infect Dis; 2021 Aug; 109():108-111. PubMed ID: 34157388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of cefiderocol, a novel siderophore cephalosporin, in a Pseudomonas aeruginosa neutropenic murine thigh model.
    Ghazi IM; Monogue ML; Tsuji M; Nicolau DP
    Int J Antimicrob Agents; 2018 Feb; 51(2):206-212. PubMed ID: 29111435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful cefiderocol therapy of severe infections due to difficult-to-treat Pseudomonas aeruginosa in two allogeneic hematopoietic stem cell transplantation recipients.
    Gras J; Villar-Fernandez S; Baylac P; Xhaard A; Valade S; Camelena F; Bercot B; Touratier S; de Fontbrune FS; Molina JM; Lafaurie M
    Ann Hematol; 2022 Jun; 101(6):1365-1367. PubMed ID: 35039899
    [No Abstract]   [Full Text] [Related]  

  • 10. Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.
    Gelfand MS; Cleveland KO
    Clin Infect Dis; 2015 Sep; 61(5):853-5. PubMed ID: 26021991
    [No Abstract]   [Full Text] [Related]  

  • 11. Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data?
    Shields RK
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compassionate Use of Cefiderocol in the Treatment of an Intraabdominal Infection Due to Multidrug-Resistant Pseudomonas aeruginosa: A Case Report.
    Stevens RW; Clancy M
    Pharmacotherapy; 2019 Nov; 39(11):1113-1118. PubMed ID: 31550054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam.
    Hernández-Tejedor A; Merino-Vega CD; Martín-Vivas A; Ruiz de Luna-González R; Delgado-Iribarren A; Gabán-Díez Á; Temprano-Gómez I; de la Calle-Pedrosa N; González-Jiménez AI; Algora-Weber A
    Infection; 2017 Feb; 45(1):115-117. PubMed ID: 27670678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
    Matinca D; Vancea D; Boboş C; Serban O
    Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
    [No Abstract]   [Full Text] [Related]  

  • 15. [Post-surgical ventriculitis due to extensively resistant Pseudomonas aeruginosa treated with intrathecal colistin. Pediatric case report and literature review].
    Abad-Restrepo J; Díaz-Díaz A; Osorio-Cadavid N
    Rev Chilena Infectol; 2018; 35(3):321-325. PubMed ID: 30534914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to the Treatment of Patients with Serious Multidrug-Resistant Pseudomonas aeruginosa Infections.
    O'Donnell JN; Bidell MR; Lodise TP
    Pharmacotherapy; 2020 Sep; 40(9):952-969. PubMed ID: 32696452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensively drug-resistant Pseudomonas aeruginosa ventriculitis and meningitis treated with intrathecal colistin.
    Karagoz G; Kadanali A; Dede B; Sahin OT; Comoglu S; Altug SB; Naderi S
    Int J Antimicrob Agents; 2014 Jan; 43(1):93-4. PubMed ID: 24239406
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics.
    Matsumoto S; Singley CM; Hoover J; Nakamura R; Echols R; Rittenhouse S; Tsuji M; Yamano Y
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The green cerebrospinal fluid.
    Escota G; Como J; Kessler H
    Am J Med; 2011 May; 124(5):411-3. PubMed ID: 21531229
    [No Abstract]   [Full Text] [Related]  

  • 20. Ceftolozane/Tazobactam Treatment of Multidrug-resistant Pseudomonas aeruginosa Infections in Children.
    Molloy L; Abdulhamid I; Srivastava R; Ang JY
    Pediatr Infect Dis J; 2020 May; 39(5):419-420. PubMed ID: 32032173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.